2017
DOI: 10.1007/s00604-017-2464-0
|View full text |Cite
|
Sign up to set email alerts
|

Lateral flow assay for carbohydrate antigen 19–9 in whole blood by using magnetized carbon nanotubes

Abstract: The authors describe a rapid, low-cost and sensitive approach for the determination of carbohydrate antigen 19-9 (CA 19-9) in whole blood by using magnetized carbon nanotube (MCNT) and lateral flow strip biosensor (LFSB). MCNTs were synthesized by depositing magnetite (Fe3O4) nanoparticles on multiwalled carbon nanotube (CNT) via co-precipitation of ferric and ferrous ions within a dispersion of shortened multiwalled CNTs. Antibody against CA 19-9 (Ab1) was covalently immobilized on the MCNTs and were used to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 31 publications
(14 citation statements)
references
References 31 publications
0
14
0
Order By: Relevance
“…In the last decade, magnetite nanoparticles (Fe 3 O 4 NPs) have attracted much attention due to biocompatibility and magnetic properties, and many studies have been done on their application . Thus, Fe 3 O 4 NPs with crystalline phase seem to be an important nanomaterial (NM) for many biomedical uses including cell therapy as cell labeling, as a tool for separate and purify cell populations, tissue repair, targeting, drug delivery, MRI, hyperthermia,, photocatalysis, ferro‐fluid technology, magneto‐caloric refrigeration, pigment, magnetic storage, magnetic ink printing, microwave absorption, biosensors, bioseparation and immune magnetic array …”
Section: Introductionmentioning
confidence: 99%
“…In the last decade, magnetite nanoparticles (Fe 3 O 4 NPs) have attracted much attention due to biocompatibility and magnetic properties, and many studies have been done on their application . Thus, Fe 3 O 4 NPs with crystalline phase seem to be an important nanomaterial (NM) for many biomedical uses including cell therapy as cell labeling, as a tool for separate and purify cell populations, tissue repair, targeting, drug delivery, MRI, hyperthermia,, photocatalysis, ferro‐fluid technology, magneto‐caloric refrigeration, pigment, magnetic storage, magnetic ink printing, microwave absorption, biosensors, bioseparation and immune magnetic array …”
Section: Introductionmentioning
confidence: 99%
“…The CNTs collected after the final washing step were dispersed in 10 mL of water for further use. A co-precipitation method was used to prepare MCNTs [20]. In brief, 0.015 mmol FeCl 3 ·6H 2 O and 0.075 mmol FeCl 2 ·4H 2 O were mixed with 10 mL of shortened CNTs.…”
Section: Methodsmentioning
confidence: 99%
“…We prepared MCNT-Ab 1 and MCNT-Ab 2 conjugates with the reported methods [20]. 0.25 mL of MCNTs was spun down and mixed with 4.8 mg EDC and 2.7 mg sulfo-NHS in 0.5 mL MES buffer (0.1 M, pH 4.7).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The fabrication of most LFIs involves combining several materials, e.g., paper membranes, Au nanoparticles, antibodies, and antigens. Despite the overwhelming number of scientific reports and discussion of how the integration of LFIs with novel materials with intrinsic properties, such as carbon nanotubes, 149,150 III-V nanostructures, 151,152 and graphene, [153][154][155] will disrupt the diagnostic market, only a few materials and techniques have made the transition from the lab bench to commercialization for disease detection during outbreaks. More efficient interactions between researchers in fields like immunology, biochemistry, materials science, diagnostics, and regulating bodies are required to accelerate the development of robust RDTs that fulfill the criteria listed by the WHO for the ideal rapid detection device during disease outbreaks, 13 Fig.…”
Section: Existing Challenges To Develop Robust Rapid Diagnostic Tests For Use During Disease Outbreaksmentioning
confidence: 99%